What Is an Atypical Infection and How Is It Diagnosed?

An atypical infection is one caused by a pathogen that does not grow on standard laboratory cultures, does not stain with the classic Gram stain used to sort bacteria, or produces symptoms that look nothing like the textbook version of the disease it causes. The term started with pneumonia in the 1930s and 1940s but has since expanded to describe a range of bacterial, viral, and zoonotic infections whose shared trait is that they dodge the usual methods of detection and diagnosis. Figuring out what is actually going on requires a mix of molecular testing, antigen detection, serology, and sometimes advanced genomic sequencing, because the pathogens involved are effectively invisible to the tools that catch most common infections.

Where the Term Came From

The word “atypical” entered infectious-disease vocabulary in the early twentieth century, when doctors knew of essentially two major causes of pneumonia: the pneumococcus and the tuberculosis bacillus. Cases that did not fit either pattern were simply called atypical. A 1938 paper by the Philadelphia physician Hobart Reimann popularized the concept, though others had used the term informally before him.¹ By the 1940s, clinicians had crystallized a syndrome: gradual onset, constitutional symptoms like fatigue and headache alongside respiratory complaints, chest X-ray findings that looked worse than the patient seemed, and a failure to respond to sulfonamides or penicillin. That failure to respond was the real tell. These patients clearly had infections, but nothing in the existing antibiotic arsenal worked, and nothing grew in the lab.

Today the label has drifted in meaning. It can refer to a specific group of pathogens, most commonly Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella species, or it can refer to any clinical picture that deviates from what a given infection is “supposed” to look like.² That double meaning causes confusion even among clinicians, but both uses share a core idea: something about this infection is not behaving the way standard tools and expectations predict.

What Makes These Pathogens Different

The classic atypical pneumonia pathogens share a biological quirk: they live inside human cells. Mycoplasma pneumoniae lacks a cell wall entirely, which is why penicillin and other antibiotics that attack cell walls are useless against it. Chlamydophila species have an unusual life cycle that alternates between an infectious form that survives outside cells and a replicating form that hides within them. Legionella thrives inside immune cells called macrophages, the very cells that are supposed to destroy bacteria. Because these organisms either lack the structures that Gram staining detects or cannot be grown on ordinary culture media, they are invisible to the front-line diagnostic steps most hospitals rely on.³

That intracellular lifestyle also dictates treatment. Standard beta-lactam antibiotics cannot reach pathogens hiding inside cells. Instead, clinicians use drug classes that penetrate cell membranes effectively: macrolides (like azithromycin), tetracyclines (like doxycycline), and fluoroquinolones (like levofloxacin).⁴ This is one of the practical reasons diagnosis matters so much. If you treat a Legionella infection with the same antibiotic you would use for a typical pneumococcal pneumonia, the patient will not improve.

How Symptoms Differ From Typical Infections

Atypical pneumonia tends to announce itself more like a bad cold or flu than the dramatic, sudden illness most people picture when they hear “pneumonia.” Headache, fatigue, a mild fever, and a sore throat are common early complaints, and a dry, persistent cough often develops without the thick, productive sputum that marks typical bacterial pneumonia.⁵ Patients frequently look and feel better than their chest X-rays suggest, which is the opposite of classic pneumonia where a patient can look gravely ill while the X-ray is catching up.

What really sets atypical infections apart is what happens outside the lungs. These are systemic infections that happen to involve the respiratory tract, not purely respiratory diseases. The pattern of involvement beyond the lungs often points toward which pathogen is responsible. Legionella, for instance, is notorious for causing gastrointestinal symptoms and confusion alongside pneumonia. Mycoplasma can trigger skin rashes, joint pain, and neurological complications. Chlamydophila infections sometimes present with laryngitis or sinusitis before any lower respiratory symptoms appear.⁶ Recognizing these extrapulmonary clues is often the first step toward suspecting an atypical pathogen rather than a typical one.

When the Patient Is the Atypical Part

The term “atypical” does not always describe the pathogen. Sometimes a perfectly ordinary infection presents atypically because of the patient. Older adults are the most important example. A urinary tract infection in a younger adult produces burning, urgency, and fever. In an older adult, the same infection may show up as sudden confusion, a fall, loss of appetite, or generalized weakness, with no fever at all.⁷ The immune system’s response changes with age, blunting the fever and localizing signs that normally guide a clinician toward the right diagnosis.⁸

Immunocompromised patients face a similar problem. People with weakened immune systems, whether from chemotherapy, organ transplants, HIV, or autoimmune medications, often present with muted or unusual symptoms. Standard diagnostic tests may behave differently in these patients because the immune response that many tests rely on to generate detectable signals is itself impaired.⁹ This makes early recognition harder at exactly the moment it matters most, since delayed treatment in immunocompromised patients can be fatal.

Viruses That Break the Mold

Atypical presentations are not limited to bacteria. Viruses can surprise clinicians too, and two examples from recent years illustrate the problem well. COVID-19 became widely known for cough, fever, and breathing difficulty, but a significant number of patients showed up with cardiac symptoms, neurological complaints, gastrointestinal problems, blood clots, or skin changes rather than respiratory illness.¹⁰ Early in the pandemic, before these atypical patterns were widely recognized, many of those patients were misdiagnosed.

Epstein-Barr virus offers an older but equally instructive example. Most people know it as the cause of mononucleosis, the “kissing disease” of sore throat, swollen glands, and exhaustion. But in children especially, Epstein-Barr can trigger complications affecting the heart, kidneys, gastrointestinal tract, and nervous system that look nothing like mono.¹¹ These atypical viral presentations are a diagnostic challenge because clinicians may not think to test for a virus when the symptoms point in a completely different direction.

Zoonotic Infections and Why They Are Easy to Miss

Some of the most diagnostically challenging atypical infections are zoonoses, diseases transmitted from animals to humans. Rickettsia species and Coxiella burnetii (the cause of Q fever) are obligate intracellular bacteria spread by ticks or contact with livestock. Their symptoms are nonspecific: fever, headache, muscle aches, sometimes a rash or a small skin eschar at the tick bite site. In one clinical series, every patient presented with fever, but rash appeared in only about half, and nearly two-thirds had low platelet counts while three-quarters had liver abnormalities.¹² Without a clear history of a tick bite or animal exposure, these infections are frequently mistaken for more common febrile illnesses.

Nontuberculous mycobacteria present a different kind of diagnostic trap. These organisms can cause lung disease that looks virtually identical to tuberculosis on imaging and clinical examination, but they require different treatment. In patients already being treated for TB who are not improving, nontuberculous mycobacterial infection is a possibility that is easy to overlook.¹³

Why Standard Cultures Fail

The most frustrating diagnostic scenario is the culture-negative infection: a patient who clearly has an infection, but whose blood or tissue cultures come back empty. Culture-negative infective endocarditis, an infection of the heart valves, is a textbook example. The causes are varied: the patient may have received antibiotics before samples were collected, the organism may need special nutrients that standard media do not provide, or the pathogen may be one that simply does not grow outside living cells.¹⁴ Coxiella burnetii, Bartonella species, and Tropheryma whipplei are among the usual suspects.

A large prospective study of culture-negative endocarditis cases found that a systematic diagnostic workup could identify a cause in roughly two-thirds of patients. Serology, particularly testing for Q fever and Bartonella, was the single most productive step, providing a diagnosis for nearly half the cases on its own. PCR testing of valve tissue added further identifications, especially for streptococci and fungi that cultures had missed.¹⁵ Zoonotic agents turned out to be the leading cause, a finding that underscores how often animal-transmitted infections hide in plain sight. Adding specific targeted PCR assays to the standard workup has been shown to boost diagnostic yield further by about a quarter.¹⁶

The Diagnostic Toolkit

Because no single test catches every atypical pathogen, diagnosis usually involves layering several approaches depending on the clinical picture.

Multiplex PCR Panels

Multiplex PCR platforms can test for dozens of bacterial and viral pathogens simultaneously from a single respiratory sample, delivering results in hours rather than the days that cultures require. In intensive care settings, one such panel showed about 90% agreement with culture for bacterial pathogens and also picked up viral coinfections that conventional methods missed entirely.¹⁷ In children, detecting atypical bacteria by multiplex PCR in the nasopharynx was strongly associated with pneumonia risk.¹⁸ The speed of these panels has real clinical impact: in one evaluation, results would have changed the antibiotic prescription in about 40% of patients.¹⁷

Urinary Antigen Testing

For Legionella specifically, urine testing is one of the fastest and most practical diagnostic tools available. At least 80% of patients with Legionella infections excrete a detectable antigen in their urine, and the test is highly specific, essentially never producing a false positive.¹⁹ A systematic review found pooled sensitivity around 79% and specificity near 100%, with sensitivity climbing to about 86% when looking specifically at the most common culprit, Legionella pneumophila serogroup 1.²⁰ The catch is that these tests reliably detect only that one serogroup, so a negative result does not rule out Legionella caused by other strains. Current guidelines recommend the test primarily for patients with severe pneumonia or known risk factors for Legionella exposure, rather than as a routine screen for everyone with a cough.²¹

Serology

Because many atypical pathogens live inside cells and resist standard culture, detecting the body’s immune response through blood antibody levels remains a cornerstone of diagnosis. Serological testing is especially important for intracellular organisms like Coxiella and Bartonella, where it may be the only practical way to confirm a diagnosis without invasive tissue sampling. Newer multiplexed approaches allow simultaneous testing for antibodies against several atypical pathogens from a single blood draw, speeding up what used to be a slow, one-pathogen-at-a-time process.¹² The main limitation is timing: antibody levels take days to weeks to rise after infection, so serology is often more useful for confirming a diagnosis in retrospect than for guiding initial treatment decisions.

Metagenomic Next-Generation Sequencing

When everything else comes back negative, metagenomic next-generation sequencing (mNGS) offers a way to identify virtually any pathogen by reading all the genetic material in a clinical sample and matching it against databases of known organisms. This approach is especially valuable in immunocompromised patients, children in intensive care, and anyone with an infection that has resisted identification by conventional methods.²² Case reports have documented mNGS catching atypical Rickettsia infections that presented so unusually that no clinician thought to order the right specific test.²³ The technology is still expensive and not universally available, but it is increasingly becoming a realistic option for cases that would otherwise go unsolved.

The Debate Over Empiric Coverage

One of the most practical questions in managing atypical infections is whether you should treat for them before you have proof. Most patients hospitalized with community-acquired pneumonia receive empiric antibiotic regimens that cover both typical and atypical pathogens, usually a beta-lactam paired with a macrolide, or a fluoroquinolone alone. The logic is straightforward: since you cannot tell typical from atypical on day one, cover both and sort it out later.

The evidence for this practice is surprisingly mixed. A Cochrane review found no survival benefit or clear improvement in clinical outcomes from empirically covering atypical pathogens in hospitalized pneumonia patients, though the comparison was mostly between fluoroquinolone monotherapy and a beta-lactam alone.²⁴ A separate meta-analysis, however, found a modest but statistically meaningful reduction in clinical failure rates when atypical coverage was included, even though mortality and other secondary outcomes did not differ.²⁵ The tension between these findings explains why guidelines still recommend broad empiric coverage for most hospitalized patients but leave room for narrowing once a pathogen is identified. Faster diagnostics like multiplex PCR panels could eventually shift this balance by making it possible to target therapy from the start rather than blanketing everything empirically.

How Common Are Atypical Pathogens

Atypical pathogens account for a meaningful share of community-acquired pneumonia worldwide, with estimates putting their contribution at roughly one in five cases. The exact proportion varies by region, season, and the age of the population being studied. In an Egyptian pediatric cohort, multiplex PCR detected atypical pathogens in 3% of children hospitalized with pneumonia, with Bordetella pertussis, not usually grouped with atypical agents, accounting for most of those cases in very young infants.²⁶ In adults, rates tend to be higher, and Mycoplasma and Chlamydophila dominate. The post-COVID-19 period has seen unusual surges of Mycoplasma pneumoniae in children, including waves in China, Europe, and North America that likely reflect shifts in population immunity after pandemic-era social distancing disrupted the usual cycles of exposure.

Complications That Outlast the Infection

Atypical infections, particularly Mycoplasma pneumoniae, can trigger immune-mediated complications that persist long after the original pathogen is cleared. Children hospitalized with Mycoplasma infections had a roughly 25% higher risk of developing autoimmune diseases in the years afterward compared to unexposed children.²⁷ The proposed mechanism is molecular mimicry: parts of the Mycoplasma bacterium resemble human tissues closely enough that the immune system, primed to attack the pathogen, accidentally turns on the body’s own cells.

Case reports have documented striking examples, including a teenager who developed a rare autoimmune eye condition called Vogt-Koyanagi-Harada disease after a Mycoplasma infection, with rising Mycoplasma antibody levels confirming the connection.²⁸ These post-infectious complications are rare individually, but they are an important reason why pinning down the original pathogen has value even after the acute illness has resolved. If a clinician knows Mycoplasma was the trigger, they can watch for autoimmune sequelae rather than being blindsided by new symptoms weeks or months later.

Legionella and Environmental Sources

Unlike Mycoplasma and Chlamydophila, which spread person to person through respiratory droplets, Legionella comes from water. It thrives in warm, stagnant water systems: cooling towers, hot tubs, decorative fountains, and large building plumbing networks where water sits at the right temperature for bacterial growth. Outbreaks are typically traced to a specific environmental source rather than to person-to-person transmission. This difference matters for diagnosis because the relevant question for a suspected Legionella case is not “who were you in contact with?” but “what water systems have you been exposed to?” Hospitals, hotels, and cruise ships are recurring settings for outbreaks precisely because they have large, complex water systems that can harbor the organism if not properly maintained.

The environmental reservoir also means that Legionella cases tend to cluster geographically and temporally, making public health surveillance and rapid urine antigen testing critical for catching outbreaks early. A single confirmed case in a building can prompt testing of the water supply and preventive measures that head off further infections before they start.

1
The Lancet Respiratory Medicine. Atypical pneumonia and the diagnosis of community-acquired pneumonia
2
PubMed Central. Atypical pneumonia–time to breathe new life into a useful term?
3
Respiratory Investigation. Atypical pneumonia: Pathophysiology, diagnosis, and treatment
4
PubMed Central. Atypical pneumonia
5
Quality in Sport. Atypical pneumonia – etiology, epidemiology, clinical presentations, diagnosis and treatment – a review of literature
6
Clinical Microbiology and Infection. The atypical pneumonias: clinical diagnosis and importance
7
Annals of Long-Term Care. Infections in Older Adults: The Art of Early Recognition
8
Emergency Medicine Clinics of North America. Genitourinary Emergencies in Older Adults
9
The Lancet Respiratory Medicine. What Is an Atypical Infection and How Is It Diagnosed?
10
PubMed Central. Extrapulmonary and atypical clinical presentations of COVID-19
11
Jornal de Pediatria. Atypical manifestations of Epstein–Barr virus in children: a diagnostic challenge
12
PubMed Central. Clinical usefulness of metagenomic next-generation sequencing for Rickettsia and Coxiella burnetii diagnosis
13
Egyptian Journal of Chest Diseases and Tuberculosis. Risk factors for atypical mycobacterial disease in patients with smear positive pulmonary TB
14
PubMed. Laboratory Approach to the Diagnosis of Culture-Negative Infective Endocarditis
15
PubMed. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases
16
PubMed Central. Blood culture-negative endocarditis Improving the diagnostic yield using new diagnostic tools
17
PubMed Central. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units
18
PubMed. Nasopharyngeal detection of atypical bacteria by multiplex polymerase chain reaction panel in acutely ill children was associated with an increased risk of pneumonia
19
PubMed. Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy
20
Respiratory Investigation. Diagnostic accuracy of urinary antigen tests for legionellosis: A systematic review and meta-analysis
21
PubMed Central. Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations
22
PubMed Central. Emerging role of metagenomic next-generation sequencing in infectious disease diagnostics: Clinical integration and future directions
23
PubMed Central. Atypical Rickettsia japonica Infection Involving Critical Illness Diagnosed by Metagenomic Next-Generation Sequencing: A Case Report
24
PubMed Central. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
25
PubMed Central. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
26
PubMed Central. The use of multiplex PCR for the detection of atypical pathogens in Egyptian children with CAP: a high rate of Bordetella pertussis in early infancy
27
PubMed Central. Investigating the occurrence of autoimmune diseases among children and adolescents hospitalized for Mycoplasma pneumoniae infections
28
American Journal of Ophthalmology Case Reports. Vogt-Koyanagi-Harada disease presenting secondary to a post-infectious Mycoplasma pneumoniae autoimmune response